Practice Question Answers: Vulvar Diseases, Part 1

1. The risk for subsequently developing squamous cell carcinoma in situ of the vulva is most strongly associated with:

a. candidiasis

b. cicatricial pemphigoid

c. lichen planus

d. lichen sclerosus

e. recurrent Trichomonas infections

2. Vitamin D supplements and topical antibiotics commonly are used to treat:

a. desquamative inflammatory vaginitis

b. dysesthetic vulvodynia

c. human papillomavirus–related severe squamous dysplasia of the vulva and vagina

d. lichen sclerosus

e. psoriasis

3. A 28-year-old diabetic woman presented to your clinic with well-developed vulvar pruritus. She was known to have an implanted copper intrauterine device. A Papanicolaou test would most likely reveal:

a. bacteria

b. herpetic virocytes

c. high-grade dysplastic squamous cells

d. koilocytic squamous cells

e. pseudohyphae

4. A 54-year-old woman with Sjögren syndrome and atrophic gastritis presented to your clinic with vulvar pruritus. Atrophy of the skin and mucosa with fissures was clinically suggestive of:

a. candidiasis

b. dysesthetic vulvodynia

c. lichen sclerosus

d. lichen simplex chronicus

e. psoriasis

5. A 48-year-old woman was referred to your clinic for evaluation of persistent burning vulvar pain of 3 months’ duration. She said she felt tired most of the time. On physical examination the vulva looked normal. Commonly this condition is associated with:

a. diabetes mellitus

b. fibromyalgia

c. hypothyroidism

d. iron deficiency anemia

e. psoriasis